Clinical Trials Browser

INDUSTRY × Interventional × Fibrolamellar hepatocellular carcinoma × Clear all

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

NCT05603572 2025-06-05

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Phase 1/2 Suspended

148 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

NCT03860272 2025-02-06

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Phase 1 Active not recruiting

499 enrolled

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer